It comes as a solution for injection to be administered by a healthcare provider under the skin.
Egrifta
Dosage & When it is to be taken
SC- The recommended dose is 2 mg once a day.When it is not to be taken (Contraindications)
Contraindicated in patients with cancer, underactive pituitary gland, pituitary gland tumor, head injury, during pregnancy, and hypersensitivity.Drug Name : Tesamorelin
This medication is a human growth hormone-releasing factor (GRF) analog, prescribed for reducing excess stomach fat in certain HIV-infected patients.Trade Names/Brand Names of Tesamorelin
International :
Egrifta